The basolateral nucleus of the amygdala (BLA) plays a significant role in mediating individual differences in the effects of fear memory on sleep. Here, we assessed the effects of antagonizing corticotropin releasing factor receptor 1 (CRFR1) after shock training (ST) on fear-conditioned behaviors and sleep. Outbred Wistar rats were surgically implanted with electrodes for recording EEG and EMG and with bilateral guide cannulae directed at BLA. Data loggers were placed intraperitoneally to record core body temperature. The CRFR1 antagonist, antalarmin (ANT; 4.82 mM) was microinjected into BLA after shock training (ST: 20 footshocks, 0.8 mA, 0.5 s duration, 60 s interstimulus interval), and the effects on sleep, freezing and the stress response (stress-induced hyperthermia, SIH) were examined after ST and fearful context re-exposure alone at 7 days (CTX1) and 21 days (CTX2) post-ST. EEG and EMG recordings were scored for non-rapid eye movement sleep (NREM), rapid eye movement sleep (REM) and wakefulness. The rats were separated into 4 groups: Vehicle-vulnerable (Veh-Vul; n = 10), Veh-resilient (Veh-Res; n = 11), ANT-vulnerable (ANT-Vul; n = 8) and ANT-resilient (ANT-Res; n = 8) based on whether, compared to baseline, the rats showed a decrease or no change/increase in REM during the first 4 h following ST. Post-ST ANT microinjected into BLA attenuated the fear-conditioned reduction in REM in ANT-Vul rats on CTX1, but did not significantly alter REM in ANT-Res rats. However, compared to Veh treated rats, REM was reduced in ANT treated rats on CTX2. There were no group differences in freezing or SIH across conditions. Therefore, CRFR1 in BLA plays a role in mediating individual differences in sleep responses to stress and in the extinction of fear conditioned changes in sleep.
Introduction
Experimental fear conditioning is an important model for examining how stressful events, through the formation of fear memories, can produce lasting effects on behavior and psychological health. In this paradigm, an association is formed between an explicit neutral cue (generally a light or auditory stimulus) or situational context and an aversive stimulus (usually footshock) (Davis, 1992) . Subsequently, presentation of the cue or context elicits behavioral and physiologic outcomes similar to those induced by the original stressor (Nijsen et al., 1998; Stiedl et al., 2004) .
Changes in sleep also can be fear-conditioned. However, fear-conditioned changes in sleep can vary depending on stressor characteristics and with individual differences. For example, rapid eye movement sleep (REM) can be reduced after training with inescapable shock (IS) and increased after training with escapable shock (ES) (Sanford et al., 2010; Yang et al., 2011) . Some outbred Wistar rats show reductions in REM during the first 4 h after training with IS whereas others show normal amounts or even increased REM shortly after training with IS (Wellman et al., 2017; Wellman et al., 2016) . Evoking contextual fear memories produce virtually identical directional changes in REM to those observed in response to the initial stressor. These differences in REM in putatively vulnerable (Vul, reduced REM) and resilient (Res, normal/increased REM) rats occur even though indices of fear (behavioral freezing) and stress (stress-induced hyperthermia (SIH)) are virtually identical across groups (Sanford et al., 2010; Wellman et al., 2017; Wellman et al., 2016; Yang et al., 2011) . The importance of differences in REM after stress is not fully understood; however, reduced and fragmented REM have been linked to the onset of posttraumatic stress disorder (PTSD) (Mellman et al., 2002; Mellman et al., 2007) , which is viewed as arising from abnormal functioning in the brain's fear system (Shvil et al., 2013) . There also is increasing evidence that REM is important for the processing of emotional (Walker and van der Helm, 2009 ) and traumatic memories (Mellman et al., 2002; Mellman et al., 2007) . Thus, REM may play a significant role in processing stressful emotion, and it may be a useful marker of differences in the stress response that are not captured by standard behavioral and physiological measures of fear memory and stress (Wellman et al., 2016) . The differences in REM in the Vul and Res rats may also reflect differences in the time course of the restoration of sleep homeostasis after experiencing stress (Tang et al., 2005) .
The basolateral nucleus of the amygdala (BLA) has an established role in the acquisition and consolidation of fear conditioning (e.g., (Cousens and Otto, 1998; Koo et al., 2004; Maren, 1998; Muller et al., 1997) ). It also regulates fear-and stress-induced alterations in sleep, especially REM , and it plays a critical role determining how fear memories impact sleep. For example, inactivation of BLA with microinjections of the GABA A receptor agonist, muscimol, prior to training with IS blocked post-training reductions in REM and attenuated contextual freezing and fear-conditioned reductions in REM (Wellman et al., 2014) . However, post-training inactivation of BLA with muscimol did not alter REM after shock training: Vul animals showed decreases and Res animals did not. Post-training inactivation of BLA did block the subsequent fear-conditioned reduction in REM in Vul rats whereas REM in the Res rats was not altered. Pre-context inactivation of BLA also attenuated the reduction in REM in the Vul rats, but did not significantly alter REM in the Res rats (Wellman et al., 2017) . The changes in REM were independent of freezing and SIH in both Vul and Res animals regardless of whether BLA was inactivated after shock training or prior to context re-exposure. These data suggest that individual differences in BLA functioning may mediate resilience and vulnerability to stress as manifested by alterations in REM.
Corticotropin releasing factor (CRF) plays a significant role in mediating central nervous system responses to stressors (Heinrichs et al., 1995; Koob, 1999) and has roles in anxiety and conditioned fear (Liang et al., 1992; Swerdlow et al., 1989) . CRF also plays a role in fearconditioned alterations in sleep and microinjections of the CRF receptor 1 (CRFR1) antagonist, antalarmin (ANT) locally in the central nucleus of the amygdala (CNA) prior to fearful context re-exposure (Liu et al., 2011) can block fear-induced reductions in REM in rats without blocking fear-induced freezing. In BLA, microinjections of ANT prior to IS can block both IS-and fear-induced reductions in REM . These alterations in REM can occur without blocking fearinduced freezing (Liu et al., 2011; Wellman et al., 2013) . It is not known whether post-training antagonism of CRFR1 in BLA plays a role in the consolidation of fear memories and their effects on REM. It also is not known whether CRFR1 in BLA plays a role in mediating individual differences in the effects of fear memory on REM. To assess these possibilities, we separated Wistar rats into Vul and Res groups based on REM amounts observed in the first 4 h after training with IS and examined stress-induced and fear-conditioned changes in sleep as previously described (Wellman et al., 2017; Wellman et al., 2016) . In a subset of animals, we microinjected ANT into BLA immediately after ST to determine whether CRFR1 in BLA has a role in mediating individual differences in ST-induced and fear-conditioned changes in sleep. Additionally, we recorded core body temperature to assess SIH as an index of the stress response and we examined behavioral freezing as an index of fear memory.
Subjects and methods

Subjects
The subjects were 37 nine-week-old, male Wistar rats obtained from Harlan Laboratories (Frederick, MD). Upon arrival, the rats were individually housed in polycarbonate cages and given ad lib access to food and water. The rooms were kept on a 12:12 light:dark cycle with lights on from 07:00 to 19:00 h. Light intensity during the light period was 100-110 lx and < 1 lx during the dark period. Ambient room temperature was maintained at 24.5 ± 0.5°C.
Surgery
Beginning one week following arrival, the rats were anesthetized with isoflurane (5% induction; 2% maintenance) and implanted with skull screw electrodes for recording their electroencephalogram (EEG) and stainless steel wire electrodes sutured to the dorsal neck musculature for recording their electromyogram (EMG). Leads from the recording electrodes were routed to a 9-pin miniature plug that mated to one attached to a recording cable. Bilateral guide cannulae (26 ga.) for microinjections into BLA were implanted with their tips aimed 1.0 mm above BLA (A 2.6, ML ± 4.8, DV 8.0 (Kruger et al., 1995) ). The recording plug and cannulae were affixed to the skull with dental acrylic and stainless steel anchor screws. During the same surgery, temperature recorders (SubCue Standard Dataloggers, Canadian Analytical Technologies Inc. Calgary, Alberta, Canada) were implanted intraperitoneally in a subset of rats. Ibuprofen (15 mg/kg) was made available in their water supply for relief of post-operative pain. All procedures were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Experimental Animals and were approved by Eastern Virginia Medical School's Animal Care and Use Committee.
Drugs
ANT (antalarmin hydrochloride, N-Butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolol[2,3-d]pyrimidin-4-amine hydrochloride) was obtained from Sigma-Aldrich, St. Louis, MO, USA. It was prepared in pyrogen-free distilled water (Vehicle (Veh); ANT: 4.82 mM) and was sonicated for at least 20 min to ensure that the drug was dissolved completely. A fresh solution was prepared for each experimental day. This dosage was chosen because we previously found that it did not alter spontaneous sleep when microinjected into BLA, but when microinjected prior to fear acquisition, it prevented both footshock and fearful context induced reductions in REM .
Procedures
All experimental manipulations were conducted during the fourth h of the light period such that sleep recording would begin at the start of the fifth h. This resulted in 8 h of light period recording on each experimental day.
Home cages were changed at least 3 days prior to each treatment day. The same room was used for animal housing and sleep recording. The microinjections and behavioral testing were conducted in a separate room from that used for recording.
Sleep recording
For recording sleep, each animal, in its home cage, was placed on a rack outfitted for electrophysiological recording and a lightweight, shielded cable was connected to the miniature plug on the rat's head. The cable was attached to a commutator that permitted free movement of the rat within its cage. EEG and EMG signals were processed by a Grass, Model 12 polygraph equipped with model 12A5 amplifiers and routed to an A/D board (Model USB-2533, Measurement Computing) housed in a personal computer. The signals were digitized at 256 Hz and collected in 10 s epochs using the SleepWave™ (Biosoft Studio) data collection program.
The rats were allowed a minimum post-surgery recovery period of 14 days prior to beginning the experiment. Once recovered, the animals were randomly assigned to one of two groups: ANT after ST (ANT; n = 16) or Veh after ST (Veh; n = 21) for studies of its effects on ST and fear. All rats were habituated to the recording cable and chamber over 3 consecutive days. Then the rats were habituated to the 5 min handling procedure necessary for microinjections over 2 consecutive days and a baseline following handling (BH) was recorded.
Microinjections
For microinjections, injection cannulae (33 ga.) were secured in place within the guide cannulae, and projecting 1.0 mm beyond the tip of the guide cannulae for delivery of drug into the target region. The injection cannulae were connected to one end of a section of polyethylene tubing that had the other end connected to 5.0 μL Hamilton syringes. The injection cannulae and tubing were prefilled with the solution to be injected. Once the cannulae were in place, bilateral microinjections of 0.5 μL (1.0 μL total volume) of either drug or vehicle were infused over 3 min. The cannulae were left in place one min preand post-injection to allow for maximal absorption of the solution.
Fear conditioning
Each ST session lasted 30 min. During this procedure, individual rats were placed in shock chambers (Coulbourn Habitest cages equipped with grid floors (Model E10-18RF) that were housed in Coulbourn Isolation Cubicles (Model H10-23)) and were allowed to freely explore for 5 min. Over the next 20 min, they were presented with 20 footshocks (0.8 mA, 0.5 s duration) at 1.0 min intervals. Shock was produced by Coulbourn Precision Regulated Animal Shockers (Model E13-14) and presented via the grid floor of the shock chamber. Five minutes after the last shock, the rats were injected with either ANT or vehicle, as noted above, then returned to their home cages.
On days 7 and 21 after training, the rats were placed back in the shock chambers and allowed to explore freely for 30 min (no shock presented) before being returned to their home cage. These context reexposures (CTX1, CTX2) were used to test for fear memory (assessed by behavioral freezing) and for post-exposure alterations in sleep.
The shock chamber was thoroughly cleaned with diluted alcohol following each session. Each session was videotaped using mini video cameras (Weldex, WDH-2500BS, 3.6 mm lens) attached to the center of the ceiling of the shock chamber for subsequent visual scoring of freezing.
Data analyses 2.5.1. Sleep
Computerized EEG and EMG records were visually scored by trained observers blind to drug condition in 10 s epochs to determine wakefulness, NREM and REM. Wakefulness was scored based on the presence of low-voltage, fast EEG and high amplitude, tonic EMG levels. NREM was characterized by the presence of spindles interspersed with slow waves, lower muscle tone and no gross body movements. REM was scored based on the presence of low voltage, fast EEG, theta rhythm and muscle atonia. Data were collapsed into two 4 h blocks (B1 & B2) and the total 8 h light period. The following sleep parameters were examined in the data analyses: total NREM (min), total REM (min); total sleep (REM + NREM), REM% (REM/total sleep × 100) and number of NREM and REM episodes (comprised of contiguous 10 s epochs of a given state).
After an initial assessment that revealed two distinct sleep responses after ST and ascertaining that baseline sleep was not significantly different among groups, the rats were separated into 4 groups: Veh-vulnerable (Veh-Vul; n = 10), Veh-resilient (Veh-Res; n = 11), ANT-vulnerable (ANT-Vul; n = 8), and ANT-resilient (ANT-Res; n = 8). The groups were formed based on whether, compared to baseline, the rats showed a decrease or no change/increase in REM during B1 following ST. The designations of vulnerable or resilient were based on accumulating data that REM plays an adaptive role in processing emotional memories (Mellman et al., 2002; Mellman et al., 2007; Walker and van der Helm, 2009 ). The groupings also reflect a greater stress-induced disruption of REM homeostasis in the Vul animals and a more rapid post-stress restoration of REM homeostasis in Res animals. The sleep data were analyzed with two-way mixed factors (Group (Veh-Vul; VehRes; ANT-Vul; ANT-Res) × Treatment (Bas; ST; CTX1; CTX2) ANOVAs with repeated measures on Treatment. The Holm-Sidak method was used to determine differences among means as appropriate (level of acceptance for significance, p < 0.05).
Freezing and Core body temperature
Videotapes of the ST and CTX sessions were scored for freezing, defined as the absence of body movement except for respiration (Blanchard and Blanchard, 1969; Doyere et al., 2000) . Freezing was scored by a trained observer blind to condition in 5 s intervals during 1.0 min observation periods over the course of the 30 min of the CTX1 and CTX2 trials. The percentage time spent freezing was calculated (FT%: freezing time/observed time × 100) for each animal for each observation period.
Freezing was scored during the 5 min pre-shock period to obtain baseline levels prior to ST. Freezing data were analyzed for the entire 30 min exposure and compared to the pre-shock period on the ST day and across groups on the CTX1 and CTX2 test days. The freezing data were analyzed with a two-way mixed factors (Group (Veh-Vul; Veh-Res; ANT-Vul; ANT-Res) by Treatment (Pre-shock; CTX1, CTX2) ANOVAs with repeated measures on Treatment. Freezing in the 5 min period immediately after ST was also compared across groups.
The Subcue Dataloggers were each programmed to record an animal's temperature every 15 min over the course of the experiment. To determine the effect of fear and shock on SIH and its relationship to sleep, temperature data for the time in the shock chamber and for the first 4 h of the sleep recording period were compared to the period 30 min prior to ST and across treatment conditions (ST and CTX1, CTX2). The temperature data were analyzed with two-way mixed factors (Group (Veh-Vul; Veh-Res; ANT-Vul; ANT-Res) × Treatment (ST; CTX1; CTX2) ANOVAs with repeated measures on Treatment. Post hoc comparisons were conducted with the Holm-Sidak method (level of acceptance for significance, p < 0.05).
Eta squared (η2) is reported for ANOVAs (Small effect = 0.01, medium effect = 0.059, large effect = 0.138) and Cohen's d is reported for pair-wise comparisons (0.2 is a small effect size, 0.5 is a modest effect size and 0.8 is a large effect size). Eta squared was calculated manually. Cohen's d was calculated using the effect size calculator at http://www.campbellcollaboration.org/escalc/html/ EffectSizeCalculator-SMD1.php.
Histology
To localize the microinjection sites, brain slices (35 μm) were made through the amygdala and the sections were mounted on slides and stained with cresyl violet. The sections were then examined in conjunction with a stereotaxic atlas (Kruger et al., 1995) to confirm cannula placements. Though there were rostral-caudal variations in the placements among animals (Fig. 1) , the histology indicated that ANT or Veh would have been infused into BLA and adjacent areas in all the rats, and all animals were used in the data analyses.
Results
Sleep
Rapid eye movement sleep
As indicated in the Methods section, the rats were grouped based on differences in REM amounts in B1 after ST compared to amounts during baseline. The groups did not significantly differ in baseline REM amounts (Mean ± SEM; Veh-Res: 16.9 ± 1.6; Veh-Vul: 17.2 ± 1.6; ANT-Res: 19.8 ± 1.9; ANT-Vul: 19.1 ± 2.7, p = 0.49) and, because of selection, during B1 of ST, the Veh-Res and ANT-Res groups showed significantly greater REM than the Veh-Vul and ANT-Vul groups and the collective Res and Vul groups did not differ with either Veh or ANT ( Fig. 2A) .
Once the groups had been formed, the subsequent analysis made comparisons across groups and recording days (baseline, ST, CTX1 and CTX2) to determine whether ANT after ST could alter the effects of fear memory on sleep and behavior. The ANOVA for REM amounts (Fig. 2 ) during B1 revealed significant Main Effects for Group (F(3,34) = 4.54, p < 0.01, η2 = 0.123), Treatment (F(3,98) = 7.09, p < 0.001, η2 = 0.071) and a Group × Treatment interaction (F(9,98) = 4.86, p < 0.001, η2 = 0.330). Subsequent comparisons were made within groups across days. In B1 of the CTX1 day, REM amount was decreased in the Veh-Vul group compared to that recorded in the Veh-Res (p < 0.05, Cohen's d = 1.244) and the ANT-Res (p < 0.05, Cohen's d = 2.160) groups. REM in the ANT-Vul (p < 0.05, Cohen's d = 1.419) group was not significantly reduced compared to either Res group (Fig. 2D) . In B1 of the CTX2 day, total REM was at baseline levels in the Veh-Vul rats suggesting that the effect on REM had extinguished whereas REM amounts in the Veh-Res rats was similar across all recording days. Surprisingly, total REM for the rats that received post-ST ANT was reduced in B1 of CTX2 compared to baseline (nominally reduced in ANT-Vul rats, p = 0.062, Cohen's d = 0.360; significantly reduced in ANT-Res rats, p = 0.037, Cohen's d = 0.635). Both ANT-Vul (p < 0.05, Cohen's d = 0.410) and ANT-Res (p < 0.05, Cohen's d = 0.429) rats showed significantly reduced REM during this period compared to the Veh-Res rats.
In B2, there was a significant Treatment Effect (F(3,98) = 3.96, p < 0.01, η2 = 0.042) for REM amount which was greater on CTX1 (p < 0.05, Cohen's d = 0.068) and CTX2 (p < 0.05, Cohen's d = 0.078) compared to baseline. However, there were no significant differences among the groups.
The analysis of the number of REM episodes (Fig. 2B , E) revealed significant Main Effects for Group (F(3,34) (Fig. 2E, H) . By comparison, there was no significant alteration in REM episode duration in either ST, CTX1 or CTX2 (Fig. 2C, F, I ).
Non-rapid eye movement sleep
There were no significant Group differences in any of the NREM measures.
The only significant alterations in NREM amounts were found in B2 (F(3,98) (Fig. 3, not indicated) . The number of NREM episodes (F(3,98) = 10.64, p < 0.001, η2 = 0.147) were reduced during B1 on ST (p < 0.05, Cohen's d = 0.143), CTX1 (p < 0.05, Cohen's d = 0.083) and CTX2 (p < 0.05, Cohen's d = 0.108) compared to baseline (Fig. 3, not indicated) .
Freezing
Freezing data was analyzed by comparing the mean percentage time spent freezing for each observation period (Pre-ST, CTX1 and CTX2). The ANOVA for freezing revealed a significant Main Effect for Treatment (F(2,54) = 63.31, p < 0.001, η2 = 0.500). The rats showed no freezing or minimal freezing during the pre-shock period, and all showed freezing during the context re-exposures. Freezing was greater However, there were no significant differences among the groups in the amount of freezing behavior exhibited during re-exposure to the context (Fig. 4) . There also was no Group differences in freezing in the 5 min period immediately after ST (see Supplemental Table 1 ).
Temperature
Temperature data were obtained in 8 Veh-Vul, 8 Veh-Res, 5 ANTVul and 5 ANT-Res rats. This was due to the fact that we implemented temperature recording after we had already collected data in some animals.
We examined temperature 30 min prior to ST, CTX1 and CTX2 as a baseline on each day. Temperature during this time period did not vary across groups or days. Subsequently, we examined temperature in two 15 min periods during exposure to the shock chamber on the ST, CTX1 and CTX2 days and we examined temperature hourly for 4 h on each day after sleep recording had begun. Each was also compared to their respective baselines.
The ANOVAs for temperature recorded in the shock chamber found a Treatment Main Effect (F(3,60) In the analysis of hourly temperature changes, significant Treatment Main Effects were found for H1 (F(3,60) = 152.95, p < 0.001, η2 = 0.691), H2 (F(3,60) = 28.25, p < 0.001, η2 = 0.345), H3 (F (3,60) = 12.25, p < 0.001, η2 = 0.157), and H4 (F(3,60) = 9.86, p < 0.001, η2 = 0.140). For each of the hourly periods, temperature on ST, CTX1 and CTX2 were greater than on baseline (at least p < 0.005 for all comparisons; see Supplemental Table 2 ). There were no significant differences between groups, or across days, for any hourly period (Fig. 6 ).
Discussion
The current study demonstrates that CRFR1 in BLA mediates the formation of fear memories that have the potential to alter REM. Post-ST antagonism of CRFR1 in BLA did not prevent distinguishing Res and L.L. Wellman et al. Hormones and Behavior 100 (2018) 20-28 Vul animals based on REM amounts after ST. However, post-ST antagonism of CRFR1 in BLA did block the conditioned reduction in REM expected following CTX1 in Vul animals. By comparison, post-ST antagonism of CRFR1 did not significantly alter REM following CTX1 in the Res animals. These effects on REM occurred without significant alterations in freezing or SIH, indicating that only the aspect of fear memory that impacted conditioned changes in REM was altered.
Fear memory, stress and sleep
Using a relatively intense fear conditioning paradigm, we have found that virtually identical footshock stressors and virtually identical fear-conditioned behavioral (freezing) and stress (SIH) responses can be followed by either increases or decreases in REM (e.g., (Wellman et al., 2017; Wellman et al., 2016) ). Thus, while studies have reported that sleep has a role in the consolidation of contextual fear memory associated with brief or mild fearful experiences (Reviewed in (Havekes et al., 2015) ), our work demonstrates that REM is not necessary for the formation of contextual fear memory associated with intensely stressful experiences, such as those modeled by our experiments. This raises questions regarding the memory and emotional processes that produce the directionally different alterations in REM, and regarding the role that REM may play after stressful and fearful experiences.
Experimental fear conditioning paradigms can engage fear memory and induce behavioral fear and stress responses, and impact sleep, without requiring a full re-experiencing of the precipitating stressful event. For these reasons, they have become important models for examining how stressful and fearful memories can contribute to the development of anxiety disorders (Stam et al., 2000) . However, the relatively extensive training paradigm we use allows the animals to engage in complex behaviors as they seek to mitigate the footshock stressor; thus, there is no reason to expect that other types of learning do not take place. Increases in REM have been associated with successful operant learning in avoidable (Smith et al., 1974; Smith and Lapp, 1986) and escapable Sanford et al., 2010; Yang et al., 2011) shock paradigms, but do not occur after failed operant learning Smith et al., 1980) . Thus, it is possible that the differences in REM in the Vul and Res animals reflect learning processes in addition to conditioned fear. Increases in REM after controllable stress (Sanford et al., 2010; Yang et al., 2011) and increases or normalization of REM after fear extinction (Wellman et al., 2008) suggest that it has a positive functional role in mediating stress outcomes. REM has been suggested to act in "decoupling" memory from its emotional charge (Walker and van der Helm, 2009 ) and in the adaptive processing of traumatic memories (Mellman et al., 2002; Mellman et al., 2007) . If this is the case, the Res and Vul animals may have different emotional responses to the footshock stressor. However, as indicated above, we have seen no obvious differences in overt fear behavior or in the stress responses (SIH) in any of the studies where we have examined the relationship between fear behavior, stress and fear conditioned changes in sleep (e.g., (Wellman et al., 2017; Wellman et al., 2016; Wellman et al., 2014; Wellman et al., 2013) ). Thus, the functional role of REM is not to simply reduce fear or ameliorate the stress response.
Fear extinction, stress and sleep
After CTX2, the Veh-Vul rats showed baseline levels of REM indicating extinction of the conditioned reduction in REM. This contrasts with REM in the Veh-Res rats which was similar across all recording days and showed no sign of a conditioned reduction. However, REM was relatively reduced in both ANT treated groups on CTX2. There was no apparent difference in the stress response as all of the animals that we obtained temperature recordings from showed increased temperature very similar to that exhibited by the Veh controls. There also was no difference in freezing between the groups on either CTX1 or CTX2, though there was a reduction in freezing across days. Thus, the difference between the Veh and ANT groups was specific to REM and occurred only after behavioral fear was extinguished. We administered ANT into BLA after ST and, as such, immediately prior to the period when fear memory should be consolidated (Graves et al., 2003) . Thus, the reduction in REM in the ANT treated rats that occurred 3 weeks later after CTX2 is difficult to explain. The experiments were conducted using different cohorts of animals across time making it doubtful that an environmental event could have been a causal factor in the difference we observed. This suggests that the effect was due to an interaction between post training microinjection of ANT and extinction memory. Unfortunately, there has been minimal investigation of the role of CRF in BLA in the modulation of extinction, and virtually all studies examined the effect of a manipulation of CRF proximal to extinction training. None have been conducted over the extended time frame of our study.
Microinjections into BLA of CRF and of the binding protein inhibitor, CRF (which increases endogenous CRF levels), prior to fear extinction did not alter extinction acquisition, but did impair extinction recall in a test administered 24 h later (Abiri et al., 2014) . By comparison, microinjections of the nonselective CRF antagonist, α-helical CRF , prior to extinction trials improved subsequent extinction recall (Abiri et al., 2014) . Subsequent work has also shown that a CRFR1 antagonist (NBI30775) in BLA can enhance extinction recall whereas increasing administration of CRF 6-33 in BLA can disrupt extinction (Hollis et al., 2016) . Interestingly, a high concentration (30 ng) of CRF microinjected into BLA prior to training impaired post-shock freezing and fear memory and when administered prior to context reexposure impaired fear expression (Abiri et al., 2014) . However, these studies implemented manipulations of the CRF system in BLA prior to extinction and used fear conditioning paradigms with 3 (Abiri et al., 2014) to 5 (Hollis et al., 2016) tone-shock pairings. Studies also were completed within 3 days of shock training. By comparison, conditioned alterations in sleep are generally larger with greater numbers of shock presentations suggesting that additional learning processes may be engaged which are responsible for conditioned alterations in REM (Sanford et al., 2003) .
We observed significant alterations in NREM across Treatment conditions and within B1 and B2. However, we did not observe any differences in NREM between groups for any of the measures we examined. Thus, it is possible that alterations in NREM may have been related to the acquisition and extinction of behavioral fear; however, we previously found no correlation between freezing amount and NREM or REM in either Res and Vul animals (Wellman et al., 2017) . There also was no obvious relationship between NREM amounts and REM in Res and Vul animals.
4.3. CRF, the amygdala, and the regulation of stress and fear-induced alterations in REM In BLA, microinjections of ANT prior to ST can block both ST-and fear-induced reductions in REM . These alterations in REM can occur without blocking fear-induced freezing (Liu et al., 2011; Wellman et al., 2013) . Thus, antagonizing CRFR1 prior to ST did not prevent the acquisition of fear memory. This finding is consistent with a previous study that found that microinjections of DMP696, a nonpeptide CRFR1 antagonist, into BLA did not significantly alter the fear acquisition (Hubbard et al., 2007) . However administering DMP696 into BLA prior to ST did reduce freezing on re-exposure to the fearful context (Hubbard et al., 2007) . Additionally, microinjections of DMP696 into BLA at 5 min or 3 h, but not 9 h, after ST reduced contextual freezing on re-exposure to the shock context alone (Hubbard et al., 2007) . Antagonizing CRF in the BLA also reduces retention of inhibitory avoidance (Roozendaal et al., 2002; Roozendaal et al., 2008) . By comparison, in our paradigm, antagonizing CRFR1 in BLA either before or after ST had no significant effect on fear behavior. The differences may be due to differences in the training paradigms. Our paradigm was more extensive (20 trials vs 5 trials) and overtraining can overcome the effects of BLA lesions on contextual fear (Maren, 1999) indicating that circuitry outside BLA can be involved in contextual fear under some circumstances (Maren, 1999) .
In addition to effects in BLA, we have found that microinjections of ANT into CNA in rats block fear-induced reductions in REM and attenuate Fos expression, a marker of neural activation, in regions important in stress and REM regulation including the hypothalamic paraventricular nucleus (PVN), locus coeruleus (LC), and dorsal raphe nucleus (DRN) (Liu et al., 2011) . However, ANT microinjected into CNA did not alter freezing in the fearful context. Microinjection of DMP696 into CNA prior to ST also did not significantly alter freezing on re-exposure to the shock context alone (Hubbard et al., 2007) . Thus, CNA may mediate fear behavior, and the effects of fear on REM, but unlike BLA, it does not appear to be involved in the formation of fear memory.
Relevance for modeling stress-related learning
Fear conditioning is an important paradigm for modeling specific features of anxiety disorders and trauma-and stressor-related disorders (e.g., PTSD) (Stockhorst and Antov, 2015) . However, the fear system typically functions to enable adaptive responses to threats (Rudy, 2014) . It is the enhanced fear learning that can occur during traumatic stress that is considered to be a critical factor in the etiology of anxiety disorders and PTSD (Bowers and Ressler, 2015; Stockhorst and Antov, 2015) . As such, stress-enhancement of classical fear conditioning is used as an animal model of PTSD (Rau et al., 2005) . However, most who undergo traumatic stress, and undoubtedly make fearful associations during the experience, do not develop persisting stress-related psychopathology (Cohen et al., 2003; Yehuda and LeDoux, 2007) ; the majority adequately cope with such experiences with only transitory detrimental effects. Thus, even trauma-related fear does not necessarily lead to PTSD. The current study and our other recent work on individual differences in fear-conditioned sleep (Wellman et al., 2017; Wellman et al., 2016) demonstrates that putatively "stress-enhanced" fear also can produce differential outcomes in individual animals.
Several studies have reported stable and robust inter-individual differences in anxiety-like behavior in Wistar rats (Borta et al., 2006; Ho et al., 2005; Naslund et al., 2015) . There have also been reports of different coping responses exhibited by rats undergoing social defeat stress (Wood, 2014; Wood et al., 2010) . We have suggested that individual differences in fear conditioned REM may be a useful marker of resilience and vulnerability that may enable improved animal models of PTSD and anxiety disorders (Wellman et al., 2016) . This suggestion was based on the findings that reduced and fragmented REM are linked to the etiology of PTSD (Mellman et al., 2002; Mellman et al., 2007) and the evolving evidence that REM plays a positive role in the processing of emotional (Walker and van der Helm, 2009 ) and traumatic memories (Mellman et al., 2002; Mellman et al., 2007) . This suggestion is also consistent with the putative more rapid restoration of REM homeostasis in resilient rats compared to vulnerable rats (Tang et al., 2005) . Differences in REM are also regulated by BLA, a core region critical for formation of fear memories (Cousens and Otto, 1998; Koo et al., 2004; Maren, 1998; Muller et al., 1997) . Future research is needed to determine additional markers that delineate Res and Vul animals, and to assess the role that REM may play in mediating differential stress outcomes.
Conclusion
Alterations in REM can be fear-conditioned and extinguished by processes that overlap yet have important differences from those that regulate established behavioral and physiological indices of fear memory. CRFR1 in BLA mediates the consolidation of fearful memories that can impact REM and may play a role in mediating subsequent extinction of effects on REM. CRFR1 in BLA may also be involved in mediating individual differences in sleep responses to fear and stress. Considering these differences in REM and other individual differences in responses to fear and stress has the potential to significantly improve understanding of fear memory and its significance for anxiety and trauma-and stressor-related disorders.
